Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Gross Profit (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -57.97%
Dec 31, 2025 4.25%
Sep 30, 2025 18.87%
Jun 30, 2025 11.55%
Mar 31, 2025 -5.73%
Dec 31, 2024 10.57%
Sep 30, 2024 -5.00%
Jun 30, 2024 0.88%
Mar 31, 2024 -1.74%
Dec 31, 2023 9.07%
Sep 30, 2023 -1.11%
Jun 30, 2023 14.20%
Mar 31, 2023 -1.25%
Dec 31, 2022 8.12%
Sep 30, 2022 0.80%
Jun 30, 2022 12.46%
Mar 31, 2022 11.99%
Dec 31, 2021 -17.43%
Sep 30, 2021 -4.44%
Jun 30, 2021 10.09%
Mar 31, 2021 -12.83%
Dec 31, 2020 6.88%
Sep 30, 2020 18.85%
Jun 30, 2020 -12.11%
Mar 31, 2020 -18.81%
Dec 31, 2019 -15.82%
Sep 30, 2019 31.15%
Jun 30, 2019 -2.45%
Mar 31, 2019 -28.04%
Dec 31, 2018 3.24%
Sep 30, 2018 -7.60%
Jun 30, 2018 15.18%
Mar 31, 2018 -4.67%
Dec 31, 2017 5.03%
Sep 30, 2017 3.74%
Jun 30, 2017 18.49%
Mar 31, 2017 -0.07%
Dec 31, 2016 7.75%
Sep 30, 2016 12.98%
Jun 30, 2016 9.97%
Mar 31, 2016 -3.05%
Dec 31, 2015 6.39%
Sep 30, 2015 8.49%
Jun 30, 2015 13.96%
Mar 31, 2015 -0.98%
Dec 31, 2014 19.23%
Sep 30, 2014 32.13%
Jun 30, 2014 37.70%
Mar 31, 2014 11.42%
Dec 31, 2013 6.29%
Sep 30, 2013 23.74%
Jun 30, 2013 17.25%
Mar 31, 2013 9.42%
Dec 31, 2012 35.09%
Sep 30, 2012 73.23%
Jun 30, 2012 37.20%
Mar 31, 2012 59.79%
Dec 31, 2011 35.84%
Sep 30, 2011 16.70%
Jun 30, 2011 225.30%